Biological and biosimilar therapies in inflammatory conditions: challenges for the Central and Eastern European countries.
Department of Health Economics, Corvinus University of Budapest, Budapest, Hungary, laszlo.gulacsi@uni-corvinus.hu.
László
L
Gulácsi
D059451:Biosimilar Pharmaceuticals / Q000191:economics / Q000627:therapeutic use*; D005060:Europe; D005380:Financing, Government; D006801:Humans; D007249:Inflammation / Q000188:drug therapy*; D018836:Inflammation Mediators / Q000191:economics / Q000627:therapeutic use*; D012051:Reimbursement Mechanisms; D013673:Technology Assessment, Biomedical
D059451:Biosimilar Pharmaceuticals; D018836:Inflammation Mediators